Type something to search...

Cancer vaccine

Personalized mRNA Cancer Vaccines in 2026: Where the Melanoma Trials Stand
Health

Personalized mRNA Cancer Vaccines in 2026: Where the Melanoma Trials Stand

A personalized mRNA vaccine plus Keytruda cut melanoma recurrence risk by 42% in a 2026 Phase 3 trial, but it is not yet FDA-approved. Here is how it works.

05 Aug, 2026·3 mins read